Titan Medical Announces Purchase Order from Medtronic

Titan Medical Inc. | May 04, 2022

Titan Medical

Titan Medical Inc. a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery announced receipt of a $2.6 million purchase order from Medtronic plc a global leader in healthcare technology.

The order covers the purchase of instruments and cameras that will be used in preclinical activities and the evaluation of Titan Medical as a potential manufacturing and supply partner for Medtronic.

Medtronic has been a great partner for Titan since 2020 and we’re excited about this opportunity to further our work together. Our manufacturing team and capabilities continue to expand at our operations in Chapel Hill. With this order, we will produce instruments and cameras for Medtronic’s evaluation and testing in addition to producing instruments and cameras for our own single-access RAS platform, Enos.”

Paul Cataford, Interim President and CEO of Titan

For clarity, these agreements are between Medtronic and Titan Medical Inc. Titan Medical is not affiliated with Titan Spine, which Medtronic acquired in 2019.

About Titan Medical

Titan Medical Inc. a medical device company headquartered in Toronto, Ontario, with operations in Chapel Hill, North Carolina, is focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point. The Enos™ robotic single access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand. The Enos system includes multi-articulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. Titan intends to initially pursue gynecologic surgical indications with the Enos


Typical rectal cancer treatment protocols are intensive and involve several steps, including invasive surgical intervention.


Typical rectal cancer treatment protocols are intensive and involve several steps, including invasive surgical intervention.

Related News


BioIntelliSense Joins Polaris Dawn Mission to Advance Understanding of Human Health in Space

BIOINTELLISENSE | November 15, 2022

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space. The BioButton® medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn mission. This historic mission will be flown by SpaceX and is scheduled to launch after March 2023. Medical and scientific research on human health in space promotes the advancement of translational technologies by adapting known technology for space applications, and by using space-based insights to improve healthcare at home. “BioIntelliSense has proudly gained industry recognition for its innovative and comprehensive portfolio of continuous multi-parameter monitoring solutions for application in the acute care environment, at home settings and now, in the next frontier of space, As a lifelong space exploration enthusiast, it is a tremendous honor to be working with TRISH on health research that can benefit astronauts and crews during commercial space flight and for the BioButton devices to be part of the upcoming Polaris Dawn mission.” -James Mault, MD, founder and CEO of BioIntelliSense The BioButton multi-parameter device is designed to be worn on the upper left chest and will passively capture trending physiologic and movement data from the Polaris Dawn crew during its milestone mission. The future of healthcare is here. Today, the BioIntelliSense Data-as-a-Service (DaaS) platform and clinical intelligence solution is commercially available and rapidly adopted by acute and post-acute providers in the U.S. along with select international markets. TRISH is proud to partner with innovative healthcare technology leaders like BioIntelliSense as we further our understanding of human health in space, Our EXPAND (Enhancing eXploration and ANalog Definition) commercial spaceflight health research platform provides unique opportunities to rapidly test technologies in orbit, as well as collect new datapoints on the health impact of spaceflight for a wider, more diverse population,said James Hury, TRISH Chief Innovation Officer and Deputy Director. BioIntelliSense (Booth #5025) and TRISH (Space Health Pavilion #2636) will be showcasing the BioButton wearable device and clinical intelligence solution at the premier HLTH 2022 conference November 13 – 16 in Las Vegas, NV. ABOUT BIOINTELLISENSE BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for remote patient monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical grade remote care from in-hospital to home. ABOUT TRANSLATIONAL RESEARCH INSTITUTE for SPACE HEALTH (TRISH) Led by Baylor College of Medicine’s Center for Space Medicine, TRISH is a consortium that includes partners Caltech and MIT. NASA recently awarded the Institute a six-year extension to further its work by delivering disruptive solutions to mitigate biomedical risks for human exploration while advancing terrestrial health technologies.

Read More


AnMed Chooses XSOLIS' AI for Utilization Management in Its Hospital System

XSOLIS | February 01, 2023

On January 31, 2023, AnMed has chosen XSOLIS, the artificial intelligence company supporting healthcare systems, to remodel its utilization management across its health systems. The XSOLIS' CORTEX platform will share real-time clinical data across its connected network of providers and players. Due to the shortage of nursing staff and increased number of patients, a technology solution would provide accurate patient status from the beginning to minimize rejections and associated interactions with payers. XSOLIS will centralize AnMed's operations, track work over its three hospitals, and connect its Physician Advisor and Utilization Management teams. In addition, CORTEX's advanced case management analytics and reporting efficiencies with AnMed's electronic medical record system will enhance the leverage time of the hospital systems. Associate Vice President of Population Health at AnMed, Suzanne Wilson, said, "When evaluating next-generation utilization management platforms, XSOLIS was in a league of its own. The healthcare industry has reached a tipping point, where improved provider-payer relations are imperative to reduce administrative waste and unnecessary friction. XSOLIS will help us achieve just that through its innovative technology." (Source – Cision PR Newswire) Chief Financial Officer at AnMed, Christine Pearson, said, "This is a challenging time for provider organizations across the U.S. By providing an automated, objective view of medical necessity, XSOLIS will help increase the efficiency of our existing staff so that we can better serve our patients." (Source – Cision PR Newswire) CEO and Co-Founder at XSOLIS, Joan Butters, said, "There is a growing need for transformative solutions as providers continue to contend with a shortage of healthcare professionals and friction across the healthcare system. We're looking forward to helping AnMed transform their operations to work more efficiently internally, as well as with payer organizations." (Source – Cision PR Newswire) About XSOLIS XSOLIS, the technology solutions and data science platform, serves hospitals and payer organizations nationwide for effective healthcare systemization, enhancing data-driven decision-making and collaboration with providers and payers. Its CORTEX, an AI platform, uses real-time predictive analytics to continuously objectify medical needs and care with appropriate settings. In addition, it offers patient status evaluation through health systems, reduces the administrative burden of hospitals, and increases automation between payers, health plans, and providers-sponsored health plans (PSHPs), inpatient as well as observation status. About AnMed AnMed, a non-profitable health system upstate in northeast Georgia and South Carolina, includes four hospital systems: AnMed Cannon in Pickens, AnMed Women's and Children's Hospital, and AnMed Rehabilitation Hospital with around 3,700 employees and 400 physicians. It provides routine care, urgent care as the requirement, life-saving emergency treatment, specialized care, home health visits, and virtual visits, as well as options to schedule an appointment, pay bills, volunteer, access medical records, donate, and find a job in its hospital systems.

Read More


Innovaccer and UpStream Healthcare Expand Partnership to Enhance Senior Care

UpStream | January 27, 2023

On January 26, 2023, Innovaccer, Inc., a data platform for healthcare, announced that it had entered a multiyear partnership with UpStream Healthcare, a value-based primary healthcare provider solution. This partnership entails UpStream more than doubling its population on Innovaccer's cloud-native platform in the coming year, scaling its exceptional value-based care model across the U.S. In April 2022, Innovaccer announced that UpStream Healthcare had selected the Innovaccer Health Cloud, Application Suite and Data Activation Platform to speed up its mission to transform senior healthcare with a full-risk model that improves outcomes, health equity, and care costs. Medicare and Medicare Advantage members on the UpStream platform have a 20-30% lower total cost of care and a 4.5-star quality rating. The company's platform physically embeds a pharmacist-led care team in every primary care physician's office and nurses who visit Medicare-eligible seniors at home. Adding to the point-of-care clinicians, other team members will close any clinical and quality gaps to care for all seniors in full-risk financial agreements. UpStream's clinical partners range from small independent primary care practices to IPAs, with two health systems and two ACO REACH entities supported. The company's data, analytics, and population health technology must scale quickly and cost-effectively to meet growing national demand. The company's platform, powered by Innovaccer Health Cloud, seamlessly integrates with EHRs of new providers and other healthcare IT. As a result, providers can easily access integrated workflows, unified patient records, and point-of-care analytics to deliver high-quality, low-cost care. The expanded partnership follows UpStream's $140 million Series B round, raised to scale its value-based care model across the nation. Since 2018, UpStream has grown to serve over 180,000 Medicare patients and 1,000 primary care physicians in three states. About Innovaccer A California-based health cloud company, Innovaccer Inc., accelerates healthcare innovation. The Innovaccer Health Cloud unifies patient data across systems and care settings, enabling healthcare organizations to develop modern, scalable applications that improve clinical, operational, and financial outcomes. Over 1,600 U.S. care settings use Innovaccer solutions, empowering more than 96,000 providers to transform care delivery and collaborate with life sciences companies and payers. KLAS and Black Book rank Innovaccer #1 in Data and Analytics and Population Health Technology, respectively. About UpStream Headquartered in Greensboro, North Carolina, UpStream is a primary healthcare solution provider that delivers value-based care to older patients and people with chronic conditions. The company offers an all-inclusive, risk-free solution for physicians that provides, finances, and sustains better outcomes by collaborating with healthcare practices and clinics. GAP-QTM (Guaranteed Advanced Payments for Quality) is UpStream's risk-free solution for physicians. GAP-QTM benefits physicians and practices by increasing income, professional satisfaction, and patients by lowering hospitalizations, decreasing copayments, and providing better benefits.

Read More